Novartis multiple sclerosis product Gilenya approved in China

Novartis multiple sclerosis product Gilenya approved in China

Submitted by admin on July 22, 2019 - 9:45am
Source: 
Pharmaceutical Business Review
News Tags: 
China
Novartis
multiple sclerosis
Gilenya
Headline: 
Novartis multiple sclerosis product Gilenya approved in China
snippet: 

The Chinese National Medical Products Administration (NMPA) approved Gilenya for relapsing forms of multiple sclerosis (RMS) for adults and children 10 years and older.

Do Not Allow Advertisers to Use My Personal information